Get startedLog in
    Picture of Flerie AB logo

    FLERIE — Flerie AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Flerie's Lipum Presents Final Results From Phase I Trial Of Sol-116

    Picture of Flerie AB logoFlerie AB
    14/04/2025 07:18
    April 14 (Reuters) - Flerie AB FLERIE.ST:

LIPUM PRESENTS FINAL RESULTS FROM PHASE I TRIAL OF SOL-116

SOL-116 WAS WELL TOLERATED ACROSS ALL DOSE LEVELS, WITH NO SERIOUS ADVERSE EVENTS DEEMED RELATED TO INVESTIGATIONAL DRUG

Source text: ID:nMFNbynqwX

Further company coverage: FLERIE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Flerie AB

    See all news